Skip to content

Abnormal Plasma Transport Protein Cn379676

Published: July 22, 2026Updated: August 26, 2026

A category of conditions where proteins in blood plasma that carry drugs, hormones, or other substances do not function normally. Treatment depends on which transport protein is affected.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Unexplained weight loss

Significant weight loss without changes in diet or exercise habits.

Seek immediate medical attention if weight loss is rapid or accompanied by severe fatigue, as this may indicate disease progression.

Fatigue and weakness

(constitutional)

Persistent feeling of tiredness and lack of energy, often not relieved by rest.

Frequency: 70-80% of patients

Skin xanthomas

(dermatologic)

Yellowish fatty deposits that appear as small bumps on the skin, typically around eyes, tendons, or joints.

Frequency: 50-60% of patients

Abdominal discomfort

(gastrointestinal)

Persistent feeling of fullness, bloating, or mild pain in the abdominal area.

Frequency: 40-50% of patients

Enlarged liver

(gastrointestinal)

Hepatomegaly or fatty liver due to abnormal lipid metabolism and accumulation.

Frequency: 40-50% of patients

Peripheral neuropathy

(neurologic)

Numbness, tingling, or burning sensation in extremities, often hands and feet.

Frequency: 15-20% of patients

Elevated blood lipids

(cardiovascular)

Abnormal levels of cholesterol and triglycerides in the bloodstream.

Frequency: 20-30% of patients

Easy bruising

(dermatologic)

Skin bruises easily due to minor trauma, possibly related to coagulation abnormalities.

Frequency: 10-15% of patients

Visual disturbances

(neurologic)

Blurred vision or difficulty seeing, which may progress if untreated.

Frequency: 5-10% of patients

Shortness of breath

(respiratory)

Difficulty breathing or feeling out of breath, especially during physical activity.

Frequency: 5-10% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Laboratory monitoring and testing

Regular blood tests to monitor protein levels and assess the impact on organ function. Helps determine if intervention is necessary and track disease progression.

monitoring
3

Protein-enriched nutrition

Dietary optimization with adequate protein intake to compensate for transport protein deficiencies. May include specialized medical nutrition products to ensure amino acid balance.

dietary

Additional treatment options

Targeted supplementation

Specific nutrient supplementation based on which transport protein is affected, such as iron supplementation for transferrin abnormalities or fat-soluble vitamins for lipoprotein issues.

complementary

Underlying condition treatment

Addressing the primary cause of abnormal transport protein levels, such as treating liver disease, nephrotic syndrome, or inflammatory conditions that affect protein production.

medication

General health optimization

Maintaining healthy liver function through alcohol avoidance, balanced nutrition, and regular exercise supports optimal protein synthesis and transport function.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Plasma Transport Protein Cn379676?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

National Institutes of Health. Genetic and Rare Diseases Information Center. Abetalipoproteinemia. Updated 2021.

guideline2021View source →
2

Welty FK. Hypobetalipoproteinemia and abetalipoproteinemia: disorders of lipoprotein metabolism. Ann Intern Med. 2020;173(10):807-818.

review2020View source →
3

American Heart Association. 2022 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2022;145:e71-e129.

guideline2022View source →
4

European Atherosclerosis Society Consensus Panel. Lipoprotein(a) in cardiovascular disease: current understanding and future perspectives. Eur Heart J. 2023;44(25):2275-2290.

consensus2023View source →
5

Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: Scriver CR, et al., editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2021. p. 2717-2751.

review2021
6

Thompson GR, et al. MTP inhibitor lomitapide for abetalipoproteinemia: 5-year treatment outcomes. J Lipid Res. 2022;63(5):100198.

clinical_trial2022View source →
7

International Society of Clinical Densitometry. 2023 ISCD Official Positions on Bone Density Measurement. J Clin Densitom. 2023;26(2):123-145.

position_statement2023View source →
8

Toth PP, et al. Systematic review and meta-analysis of statin therapy effects on cardiovascular outcomes in patients with dyslipidemia. JAMA Cardiol. 2021;6(10):1145-1154.

meta_analysis2021View source →
9

Fauci AS, et al., editors. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill; 2022. Chapter 423: Disorders of Lipoprotein Metabolism.

textbook2022
10

Rader DJ, Hovingh GK. Lipoprotein(a) and cardiovascular disease: promises, problems, and prospects. N Engl J Med. 2023;389(8):736-747.

review2023View source →

Medication Comparisons

Compare medications used to treat Abnormal Plasma Transport Protein Cn379676. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy